Search This Blog

Showing posts with label regulation. Show all posts
Showing posts with label regulation. Show all posts

Tuesday, October 29, 2019

Automibile Emissions

The nation is preparing for a showdown on automobile emission standards (G.M., Fiat Chrysler and Toyota Side With Trump on Emissions. New York Times, October 29, 2019: 1, 24). The UUS government wishes to freeze the standard at the current level, California and several other states wish to continue to tighten standards to the levels proposed by the Obama administration. Several automakers decided to work with California to reduce emissions; others were silent.

These silent automobile manufacturers have now come out in support of the current administration’s position: reduced standards and higher levels of pollution.

It is interesting to note that most of the  firms supporting higher standards are those firms that already meet the current standard; only Toyota. The firms supporting Trump are those that are failing miserably to meet the current standard:
·       Meet Current Automobile emission standards
o   Support Trump’s relaxation of standards
§  Toyota
o   Support California’s more stringent standards
§  BMW
§  Ford; Ford almost meets the current standard
§  Honda
§  Volkswagen
·        Are Failing to Meet Current Automobile emission standards
o   Support Trump’s relaxation of standards
§  Fiat Chrysler
§  General Motors
o   Support California’s more stringent standards
§  No one
It is sad to see that the Trump administration’s zeal for regulatory roll-back is rewarding those firms that have lagged in developing effective reductions in automobile emissions. It is the firms that have made the necessary investment in pollution control that the world needs to be rewarded.
It will be interesting to see which firms are successful in the market.

Friday, October 19, 2012

Regulation and Compounding Pharmacies

In the article, Spotlight on Compounding Medicines, Roni Rabin
provides a list of six questions that patients should ask of their
prescribing doctors and the pharmacy that fills the prescription
(Science Times, October 156th.: L1, L6).

The questions range from challenging your doctor as to whether an
ordinary FDA approved drug might be substituted, ask the pharmacist
whether they have experience compounding this kind of drug, be
vigilant about IV drugs, and so on.

Now I am all in favor of "caveat emptor," but this is beyond
ridiculous. It requires patients, who may well be sick, to challenge
and perhaps alienate their health care providers. This is an
unreasonable expectation.

We, the patients are not medical experts, that is why we go for care
to these specialists.  In a perfect world we would be able to rely on
the professionalization of providers. However this world is not
perfect so my cry is for increased government regulation and
inspection of the compounding pharmacies.

This will require financial resources to hire regulators, but we will
all benefit from the security; a security which we cannot be expected
to provide for ourselves.



Sent to New York Times

Thursday, April 19, 2012

Liberty Mutual

Mr. Syre is quite correct,   the policy holders and owners of Liberty
Mutual are quite powerless to affect the fate of the Company (Ted
Kelly's pay shocking on several levels, Boston Globe, April 13, 2012).

Several years ago in 2002, with no compensation to policy holders and
owners, the Company adopted a byzantine legal and organizational
structure that seems to have allowed the Board to spend freely with
little or no accountability!

  * The lines of insurance are provided by three companies which are
wholly owned subsidiaries of Liberty Mutual Group, Inc..
  * Liberty Mutual Group Inc. is a wholly owned subsidiary of LMHC
Massachusetts Holdings Inc.
  * LMHC Massachusetts Holdings, Inc. is, in turn, a wholly owned
subsidiary of Liberty Mutual Holding Company, Inc.

The insurance commissioner allowed the Company to adopt this structure
after the Company threatened to move its headquarters out of state.

This three-tier structure leaves lots of questions unanswered: Was the
structure designed to weaken accountability or, as the company
claimed, improve access to the capital markets? At what level were the
extravagant expenses on a fleet of five airplanes and excessive
executive salaries incurred? At what level were they authorized? At
what level were the benefits received? Finally, how much did these
costs detract from the benefits received by the owners and  policy
holders?

I hope the Commissioner will get answers to these questions. We policy
holders don't know where to begin.


Sent to Boston Globe

Sunday, May 29, 2011

States Loosen Insurance Rules

I cannot believe that the states are encouraging irresponsible behavior by the Insurance Companies (Seeking Business, States Loosen Insurance Rules. New York Times, May 9, 2011: A1, A3).

After the catastrophic collapse of the mortgage and insurance markets of the late 2000's, I would have thought that states would ratchet up the rules rather than loosen them. It is highly risky to allow captive reinsurers to operate with high leverage. Any reverses will ricochet destructively through the economy.

I lived in Maryland when the state chartered Savings and Loan Companies failed and the State reneged on its underlying commitment to insure the deposits. Many ordinary people lost their savings.

The states should ensure that the firms they charter undertake their activities in a prudent and responsible manner.

Business Focus

Two stories in today's New York Times discouraged me. First was the continuing and long standing complaint that the Nuclear Regulatory Commisision was a captive of that industry and that important safety precautions were not made and those failures were not punished by the NRC (Nuclear Agency Is Criticized as Too Close to Its Industry. New York Times, May 8, 2011: A1). Second was the failure of major data archives to protect the identity of the data stored therein (There's No Data Sheriff on the Wild Web. New York Times Week in Review, May 8, 2011: 2).

In both cases, essential security features were not put in place because they were "too expensive."

When was it that American Industry turned from an emphasis on technical rigor and pride in doing an excellent job to the present focus on parsimony? Parsimony, that is, when it comes to providing adequate products and services but generosity in rewarding the top echelon of the managerial team.

We have to return to that focus on a job well done despite the cost or we will suffer unimaginable problems in the years ahead. Let's start with really tightening up the safety levels of our aging Nuclear Reactors. Apropos Vermont, lying about the existence of underground pipes should be a clear basis for not issuing an operating permit for another twenty years.